Nyrada (ASX:NYR)
Company Profile
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Nyrada.
RELATED STOCKHEAD STORIES
Health Check: With a US military win, Bio-Gene declares germ warfare on mosquitos, ticks and bed bugs
Health Check: Local biotech starred in 2024, but the rising tide did not lift all boats
Health Check: The robots are taking over biotech stock selection
October Health Winners: Uscom, Respiri lead sluggish sector, but ‘time in the market, not timing, is key’
Rise and Shine: Everything you need to know before the ASX opens
Health Check: Approval clock ticks as FDA accepts Telix’s brain diagnostic marketing application
ASX Small Caps Lunch Wrap: Local markets are lower and Albo bought a beach house
Health Check: Rats – and investors – are happy as Nyrada forges ahead with its first human trial
Top 10 at 11: It’s all about a new drug, uranium and Mongolian coal seam gas today
Market Highlights: ASML’s gloomy outlook triggers Nasdaq sell-off; as expert flags overvalued ASX stocks
Tony’s Takeaway: Biotech buffet on the ASX
Market Highlights: Dow Jones at record after blowout jobs report; and 5 ASX small caps to watch today
Rise and Shine: Everything you need to know before the ASX opens
